Polomar Health Services, Inc. (PMHS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 1.5M 3M 4.5M Q2 '24: 66.8K Q3 '24: 55.2K Q4 '24: 58.8K Q1 '25: 49.8K Q2 '25: 40.7K Q3 '25: 37K Q4 '25: 648.2K Q1 '26: 1.6M Q2 '26: 3.2M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Gross Profit TTM

0 700K 1.4M 2.1M Q2 '24: 48K Q3 '24: 36.9K Q4 '24: 30.9K Q1 '25: 31.4K Q2 '25: 24.9K Q3 '25: 20.4K Q4 '25: 460.1K Q1 '26: 1M Q2 '26: 1.9M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Income TTM

-12M -8M -4M 0 4M 8M 12M Q4 '22: -181.5K Q1 '23: -269K Q2 '23: -346.3K Q3 '23: -467.4K Q4 '23: -410K Q1 '24: -480.6K Q2 '24: -580.4K Q3 '24: -704.9K Q4 '24: -1.3M Q1 '25: -1.6M Q2 '25: -1.9M Q3 '25: -2.3M Q4 '25: -10.6M Q1 '26: -10.1M Q2 '26: -9.4M Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Net Income TTM

-12M -8M -4M 0 4M 8M 12M Q4 '22: -181.1K Q1 '23: -268.7K Q2 '23: -345.9K Q3 '23: -504.7K Q4 '23: -480.5K Q1 '24: -551.2K Q2 '24: -651K Q3 '24: -750.1K Q4 '24: -1.3M Q1 '25: -1.6M Q2 '25: -2.1M Q3 '25: -2.4M Q4 '25: -10.7M Q1 '26: -10.3M Q2 '26: -9.5M Q4 '22 Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Cost of Revenue TTM

0 500K 1M 1.5M Q2 '24: 18.9K Q3 '24: 18.3K Q4 '24: 27.9K Q1 '25: 18.4K Q2 '25: 15.8K Q3 '25: 16.6K Q4 '25: 188.1K Q1 '26: 641.8K Q2 '26: 1.2M Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Operating Cash Flow TTM

-1.1M -700K -350K 0 350K 700K 1.1M Q2 '23: -193.1K Q3 '23: -329.8K Q4 '23: -534.3K Q1 '24: -626K Q2 '24: -782.5K Q3 '24: -924.9K Q4 '24: -1M Q1 '25: -900.6K Q2 '25: -840.5K Q3 '25: -901K Q4 '25: -396K Q1 '26: -316K Q2 '26: -7K Q2 '23 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

Free Cash Flow TTM

-1.2M -800K -400K 0 400K 800K 1.2M Q4 '24: -1.1M Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 40M 80M 120M Q2 '22: 313.6K Q3 '22: 266.2K Q1 '23: 108.5M Q2 '23: 108.6M Q3 '23: 27.7M Q1 '24: 27.7M Q2 '24: 27.7M Q3 '24: 27.7M Q1 '25: 27.7M Q2 '25: 27.7M Q3 '25: 28M Q1 '26: 28M Q2 '26: 28.1M Q2 '22 Q1 '23 Q3 '23 Q2 '24 Q1 '25 Q3 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q4 '23: -0.02 Q1 '24: -0.03 Q2 '24: -0.04 Q3 '24: -0.04 Q4 '24: -0.06 Q1 '25: -0.07 Q2 '25: -0.08 Q3 '25: -0.09 Q4 '25: -0.39 Q1 '26: -0.37 Q2 '26: -0.35 Q4 '23 Q2 '24 Q4 '24 Q2 '25 Q4 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.